- Home
- WINT vs AUUD Comparison
WINT vs AUUD Comparison
Compare WINT & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- AUUD
- Stock Information
- Founded
- WINT 1992
- AUUD 2012
- Country
- WINT United States
- AUUD United States
- Employees
- WINT N/A
- AUUD N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- AUUD Computer Software: Prepackaged Software
- Sector
- WINT Health Care
- AUUD Technology
- Exchange
- WINT Nasdaq
- AUUD Nasdaq
- Market Cap
- WINT 2.9M
- AUUD 3.1M
- IPO Year
- WINT 1995
- AUUD 2021
- Fundamental
- Price
- WINT $0.31
- AUUD $0.49
- Analyst Decision
- WINT Hold
- AUUD
- Analyst Count
- WINT 1
- AUUD 0
- Target Price
- WINT $7.00
- AUUD N/A
- AVG Volume (30 Days)
- WINT 1.2M
- AUUD 131.4K
- Earning Date
- WINT 11-27-2024
- AUUD 11-07-2024
- Dividend Yield
- WINT N/A
- AUUD N/A
- EPS Growth
- WINT N/A
- AUUD N/A
- EPS
- WINT N/A
- AUUD N/A
- Revenue
- WINT N/A
- AUUD N/A
- Revenue This Year
- WINT N/A
- AUUD N/A
- Revenue Next Year
- WINT N/A
- AUUD N/A
- P/E Ratio
- WINT N/A
- AUUD N/A
- Revenue Growth
- WINT N/A
- AUUD N/A
- 52 Week Low
- WINT $0.32
- AUUD $0.46
- 52 Week High
- WINT $14.75
- AUUD $11.75
- Technical
- Relative Strength Index (RSI)
- WINT 28.66
- AUUD 46.25
- Support Level
- WINT $0.33
- AUUD $0.46
- Resistance Level
- WINT $0.42
- AUUD $0.55
- Average True Range (ATR)
- WINT 0.03
- AUUD 0.05
- MACD
- WINT 0.02
- AUUD -0.01
- Stochastic Oscillator
- WINT 1.91
- AUUD 35.58
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products include Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.